Foghorn Therapeutics Inc (FHTX)

SG&A Expense Growth

-3.45%

Quarterly · Period ending:

FHTX logo

FHTX SG&A Expense Growth

Latest reported-3.45%
FHTX Quarterly SG&A Growth (QoQ) (0.00% → -3.45%)
High-resolution chart · PNG

FHTX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Foghorn Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-3.4493%
-3.1779%
2.1798%
-3.0603%
-5.2079%
13.9462%
-8.8653%
-4.8328%
-4.9935%
9.7978%
-15.4791%
-1.107%
-2.7775%
9.9084%
-1.2932%
3.3879%
6.7627%
13.9608%
9.022%
18.579%
4.435%
2.8734%
78.4344%
33.6996%
-13.9577%
33.3133%
-7.854%
11.33%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.